Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Operations and Comprehensive (Loss)

v3.19.3.a.u2
Condensed Consolidated Interim Statements of Operations and Comprehensive (Loss) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Condensed Consolidated Interim Statements of Operations and Comprehensive (Loss)        
Sales $ 158,005 $ 930,257 $ 1,230,074 $ 1,978,675
Cost of Sales 143,595 450,304 562,887 1,087,540
Gross Margin 14,410 479,953 667,187 891,135
Operating expenses        
Sales and marketing 480,834 515,439 1,649,340 1,485,423
Research and development 1,021,418 779,283 2,724,000 2,135,075
General and administrative 1,087,431 1,022,024 3,129,063 2,932,980
Share-based compensation expense (Note 11) 447,219 191,634 1,373,195 1,226,374
Amortization (Note 4) 69,314 69,314 207,943 209,682
Depreciation (Note 7) 27,636 15,969 78,665 50,190
Total operating expenses 3,133,852 2,593,663 9,162,206 8,039,724
Other (income) expenses        
Accretion expense 0 316,642 0 2,421,060
Fair value adjustment 0 0 0 (337,923)
(Gain) on mark to market re-evaluation 0 0 0 (2,048,697)
Other income (107,730) 0 (108,016)  
Other expense 11,798 1,520 197,119 61,652
Foreign exchange (53,561) (47,709) (110,844) (116,715)
Total other expenses (income) (149,493) 270,453 (21,741) (20,623)
Net (loss) and comprehensive (loss) for the period $ (2,969,949) $ (2,384,163) $ (8,473,278) $ (7,127,966)
Loss per share - basic and diluted $ (0.58) $ (0.91) $ (1.99) $ (3.14)
Weighted average number of shares outstanding - basic and diluted 5,126,834 2,611,538 4,264,723 2,267,906